CALOSYN PHARMA, INC. — Form D

CALOSYN PHARMA, INC. of Shreveport, LA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-07. The offering totals $2.0M, of which $750K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Richard R BabbDirectorBaton Rouge, LA
Ross P BarrettDirectorShreveport, LA
William R GrimesDirectorKingwood, TX
Joseph P LovettDirectorBaton Rouge, LA
David P WaddellDirectorShreveport, LA
Richard R BabbExecutive OfficerBaton Rouge, LA
Ross P BarrettExecutive OfficerShreveport, LA
William R GrimesExecutive OfficerKingwood, TX
Ross BarrettDirectorShreveport, LA
Stephen SnowdyDirectorBrookhaven, GA
Stephen SnowdyExecutive OfficerBrookhaven, GA
Mike ShermanDirectorDurham, NC
Joseph LovettDirectorHouston, TX
Joseph F LovettDirectorPlymouth Meeting, PA
Ross F BarrettDirectorBaton Rouge, LA
David WaddellDirectorAtlanta, 2Q
David F WaddellDirectorShreveport, LA
Stephen F SnowdyDirectorMemphis, TN
Stephen F SnowdyExecutive OfficerMemphis, TN
Martin BeckerDirectorSharon, MA
Martin BeckerExecutive OfficerSharon, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2012-02-29D$2.1M$310K
2010-04-13D/A$3.3M$1.9M
2009-04-13D$400K$400K

More